Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Momenta Pharmaceuticals Inc

+ Add to Watchlist

MNTA:US

19.8800 USD 0.5700 2.95%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Momenta Pharmaceuticals Inc (MNTA)

Open: 19.3700 Day's Range: 19.0800 - 19.9100 Volume: 785,840
Previous Close: 19.3100 52wk Range: 9.3800 - 20.7500 1-Yr Rtn: +64.03%

Stock Chart for MNTA

No chart data available.
  • MNTA:US 19.8800
  • 1D
  • 1M
  • 1Y
19.3100
Interactive MNTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNTA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.7800
Est. EPS (USD) (12/2015) -0.5680
Est. PEG Ratio -
Market Cap (M USD) 1,286.42
Shares Outstanding (M) 64.71
30 Day Average Volume 1,386,875
Price/Book (mrq) 5.2712
Price/Sale (ttm) 20.7882
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNTA

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

Craig A WheelerPresident/CEORichard P Shea "Rick"Senior VP/CFO
Michael FrankenSenior VP/Pres:Biosimilars BusBruce A LeicherSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for MNTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil